SENS 3

Scientific Program of the upcoming third conference "Strategies for Engineered Negligible Senescence" (SENS), Cambridge, England, September, 2007.


Greetings,

I am pleased to get an e-mail message from the organizer of the third Strategies for Engineered Negligible Senescence (SENS) conference, Dr. Aubrey de Grey, which in fact represents a public announcement to share:

I am writing to notify you that registration and abstract submission are now open for the third Strategies for Engineered Negligible Senescence(SENS) conference, to be held at Queens' College, Cambridge, England on September 6th-10th 2007. The early registration and abstract submission deadlines are both June 15th. All details, including forms for abstract submission and online registration, are at the conference website:

http://www.sens.org/sens3/

The preliminary program already has 48 confirmed speakers, all of them world leaders in their field. As for previous SENS conferences, the emphasis of this meeting is on "applied gerontology" -- the design and implementation of biomedical interventions that may, jointly, constitute a comprehensive panel of rejuvenation therapies, sufficient to restore middle-aged or older laboratory animals (and, in due course, humans) to a youthful degree of physiological robustness. The list of sessions and confirmed speakers is as follows:

New pharmaceutical interventions in aging: Patrizia D'Alessio, Laura Dugan, Randy Strong

Immunotherapy against cancer: Zheng Cui, Robert Hawkins, Claudia Gravekamp

Persistent viruses in aging: Ruth Itzhaki, Ed Mocarski, Rita Effros, Arne Akbar

Protecting the brain (genes and delivery): Elizabeth Corder, Pedro Alvarez

Damage to long-lived intracellular molecules: Sataro Goto, Kim Janda, Paola Scaffidi

Non-insertional gene therapy: Nicola Philpott, Michele Calos, Fyodor Urnov

Rescue of mitochondrial mutations: Ian Holt, Marisol Corral-Debrinski, Volkmar Weissig, Samit Adhya

Telomeres and cell senescence: Mary Perry, Gillian Butler-Browne, Lenhard Rudolph, Walter Berger

Non-specific nuclear DNA damage in aging: Jan Vijg, Michael Siciliano, Aubrey de Grey

Deriving autologous embryonic stem cells: Chang-Kyu Lee, Wolfgang Engel, Miodrag Stojkovic

Regeneration of complex structures: Stephen Minger, Chris Mason, David Gardiner

Eliminating beta-amyloid: Ashley Bush, Beka Solomon, Yoh Matsumoto, David Morgan

Repair and turnover of extracellular material: Robin Franklin, Dwight Towler, Cato Laurencin

Long-term goals of biomedical gerontology: Chris Phoenix, Ben Best, Ray Kurzweil

Outreach to key communities: Linda Powers, Michael Rose, Huber Warner, Bernard Siegel

In addition, there will be at least a dozen short talks selected from submitted abstracts, as well as poster sessions each evening. Authors of short talks and posters will, like the invited speakers, be invited to submit a paper summarising their presentation for the proceedings volume, which will be published in the nigh-impact journal Rejuvenation Research early in 2008.

Please note that registration fees are fully inclusive of accommodation and all meals.

I hope to welcome you to Cambridge in September!

Cheers, Aubrey

Aubrey de Grey
Organiser, SENS 3
Chairman and Chief Science
Officer, Methuselah Foundation
Editor-in-Chief, Rejuvenation Research
(impact factor 8.571)